Genmab is a leading international biotech company
It is our aspiration for the future that by 2030, our “knock-your-socks-off” (KYSO) antibody medicines are fundamentally transforming the lives of people with cancer and other serious diseases.
Globally, we employ more than 1500 people at our headquarters in Denmark and our offices in the Netherlands, the United States and Japan.
Kalvebod Brygge 43
1560 Copenhagen V
Phone +45 7020 2728
CVR no. 2102 3884
LEI Code 529900MTJPDPE4MHJ122
3584 CT Utrecht
P.O. Box 85199
3508 AD Utrecht
Phone +31 30 2 123 123
CVR Utrecht 30169902
VAT no. NL8095.75.000.B.01
Have a general inquiry?
Contact us for medical information and queries about a specific compound or program or how to participate in a clinical trial.
Our value of integrity and doing the right thing means that there may be times we need to speak up about behavior that is suspected may violate our policies, standards or even the law. If you suspect or observe such behavior, we ask our people to raise such concerns through any of the channels available. Genmab also encourages external partners, vendors and stakeholders to speak up and raise such concerns as they may relate to our business.
Join our mission
Be a part of our team and help transform the future of cancer treatment
Putting our expertise to work
See how we put our in-depth knowledge of antibody biology into action
News, events and more
Get the latest stock information and news about Genmab